/INSP
INSP Stock - Inspire Medical Systems, Inc.
Healthcare|Medical - DevicesNYSE
$92.46-4.61%
$4.47 (-4.61%) • Jan 13
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.8
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.91
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+44.1%upside
Target: $133.23
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for INSP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$91.54 – $93.38
TARGET (TP)$133.28
STOP LOSS$85.06
RISK/REWARD1:5.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.73
52W High$203.12
52W Low$70.77
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $802.80M | $624.80M | $407.86M | $233.39M | $115.38M |
| Gross Profit | $679.82M | $528.22M | $341.74M | $200.12M | $97.76M |
| Gross Margin | 84.7% | 84.5% | 83.8% | 85.7% | 84.7% |
| Operating Income | $36.08M | $-40,271,000 | $-47,592,000 | $-39,850,000 | $-56,208,000 |
| Net Income | $53.51M | $-21,153,000 | $-44,881,000 | $-42,042,000 | $-57,203,000 |
| Net Margin | 6.7% | -3.4% | -11.0% | -18.0% | -49.6% |
| EPS | $1.80 | $-0.72 | $-1.60 | $-1.54 | $-2.19 |
Company Overview
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
INSPBeat Rate
100%
Last 18 quarters
Avg Surprise
+151.4%
EPS vs Estimate
Beats / Misses
18/0
Last 12 quarters
Latest EPS
$0.38
Q4 2025
EPS Surprise History
Q1 24
+644.4%
$0.49vs$-0.09
Q2 24
+46.0%
$-0.34vs$-0.63
Q3 24
+328.6%
$0.32vs$-0.14
Q4 24
+650.0%
$0.60vs$0.08
Q1 25
+55.4%
$1.15vs$0.74
Q2 25
+143.5%
$0.10vs$-0.23
Q3 25
+104.5%
$0.45vs$0.22
Q4 25
+353.3%
$0.38vs$-0.15
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 11, 2026 | $0.70 | — | — | — |
Q4 2025 | Nov 3, 2025 | $-0.15 | $0.38 | +353.3% | ✓ BEAT |
Q3 2025 | Aug 4, 2025 | $0.22 | $0.45 | +104.5% | ✓ BEAT |
Q2 2025 | May 5, 2025 | $-0.23 | $0.10 | +143.5% | ✓ BEAT |
Q1 2025 | Feb 10, 2025 | $0.74 | $1.15 | +55.4% | ✓ BEAT |
Q4 2024 | Nov 4, 2024 | $0.08 | $0.60 | +650.0% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $-0.14 | $0.32 | +328.6% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $-0.63 | $-0.34 | +46.0% | ✓ BEAT |
Q1 2024 | Feb 6, 2024 | $-0.09 | $0.49 | +644.4% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $-0.53 | $-0.29 | +45.3% | ✓ BEAT |
Q3 2023 | Aug 1, 2023 | $-0.51 | $-0.41 | +19.6% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $-0.70 | $-0.53 | +24.3% | ✓ BEAT |
Q1 2023 | Feb 7, 2023 | $-0.57 | $0.10 | +117.5% | ✓ BEAT |
Q4 2022 | Nov 1, 2022 | $-0.75 | $-0.60 | +20.0% | ✓ BEAT |
Q3 2022 | Aug 2, 2022 | $-0.59 | $-0.53 | +10.2% | ✓ BEAT |
Q2 2022 | May 3, 2022 | $-0.78 | $-0.61 | +21.8% | ✓ BEAT |
Q1 2022 | Feb 8, 2022 | $-0.47 | $-0.09 | +80.9% | ✓ BEAT |
Q4 2021 | Nov 2, 2021 | $-0.61 | $-0.38 | +37.7% | ✓ BEAT |
Q3 2021 | Aug 3, 2021 | $-0.61 | $-0.48 | +21.3% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about INSP
What is INSP's current stock price?
Inspire Medical Systems, Inc. (INSP) is currently trading at $92.46 per share. The stock has moved -4.61% today.
What is the analyst price target for INSP?
The average analyst price target for INSP is $133.28, based on 1 analyst.
What sector is Inspire Medical Systems, Inc. in?
Inspire Medical Systems, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NYSE exchange.
What is INSP's market cap?
Inspire Medical Systems, Inc. has a market capitalization of $2.74 billion, making it a mid-cap company.
Does INSP pay dividends?
No, Inspire Medical Systems, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADUS
Addus HomeCare Corporation
$109.65
Mkt Cap: $2.0B
AORT
Artivion, Inc.
$42.90
Mkt Cap: $2.0B
ARDT
Ardent Health Partners, LLC
$8.84
Mkt Cap: $1.3B
BKD
Brookdale Senior Living Inc.
$11.20
Mkt Cap: $2.7B
ETNB
89bio, Inc.
$14.84
Mkt Cap: $2.2B
ITGR
Integer Holdings Corporation
$82.74
Mkt Cap: $2.9B
LMAT
LeMaitre Vascular, Inc.
$83.34
Mkt Cap: $1.9B
PINC
Premier, Inc.
$28.26
Mkt Cap: $2.3B
PRCT
PROCEPT BioRobotics Corporation
$30.58
Mkt Cap: $1.7B
RCUS
Arcus Biosciences, Inc.
$22.74
Mkt Cap: $2.5B
Explore stocks similar to INSP for comparison